| Date Filed | Type | Description |
| 06/16/2023 |
4
| Shepard Jay (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 5,150 shares
@ $0
Granted 21,000 options to buy
@ $1.37, valued at
$28.8k
|
|
| 05/16/2023 |
4
| Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 4,274 restricted stock units
@ $0 |
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| Shepard Jay (Director) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC|
Txns:
| Granted 24,727 shares
@ $0
Granted 10,830 shares
@ $0 |
|
| 12/03/2020 |
3
| Shepard Jay (Director) has filed a Form 3 on IRONWOOD PHARMACEUTICALS INC |
| 05/29/2020 |
4
| Shepard Jay (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 6,106 shares
@ $0 |
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/09/2020 |
4
| Shepard Jay (Former Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Disposed/sold 9,291 shares
@ $0 |
|
| 01/16/2020 |
4
| Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 12,821 restricted stock units
@ $0
Granted 20,000 options
@ $3.35, valued at
$67k
|
|
| 01/16/2020 |
3
| Shepard Jay (Director) has filed a Form 3 on INOVIO PHARMACEUTICALS, INC. |
| 01/09/2020 |
4
| Shepard Jay (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 5,075 options
@ $13.77, valued at
$69.9k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2019 |
4
| Shepard Jay (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 4,967 shares
@ $0 |
|
| 05/13/2019 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Sold 1,192 shares
@ $6.11, valued at
$7.3k
|
|
| 03/04/2019 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 116,000 options
@ $5.83, valued at
$676.3k
|
|
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2018 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Sold 3,484 shares
@ $3.224, valued at
$11.2k
|
|
| 12/19/2018 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Aravive, Inc.|
Txns:
| Sold 11,247 shares
@ $3.962, valued at
$44.6k
|
|
| 05/29/2018 |
4
| Shepard Jay (Director) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 18,700 options to buy
@ $37.69, valued at
$704.8k
|
|
| 05/29/2018 |
3
| Shepard Jay (Director) has filed a Form 3 on Esperion Therapeutics, Inc. |
| 05/23/2018 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Versartis, Inc.|
Txns:
| Sold 9,232 shares
@ $1.5, valued at
$13.8k
|
|
| 02/12/2018 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Versartis, Inc.|
Txns:
| Sold 14,446 shares
@ $1.8, valued at
$26k
|
|
| 12/22/2017 |
4
| Shepard Jay (President and CEO) has filed a Form 4 on Versartis, Inc.|
Txns:
| Granted 223,000 shares
@ $0 |
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|